Skip to content
Skip to footer
SMURF-Therapeutics
Home
About Us
Management and Team
Scientific Advisory Board
Expertise
Technology
Pipeline
Resources
News and Media
Press Releases
Events & Presentations
In the news
News archives
Contact Us
FOR INVESTORS
Close
Home
About Us
Management and Team
Scientific Advisory Board
Expertise
Technology
Pipeline
Resources
News and Media
Press Releases
Events & Presentations
In the news
News archives
Contact Us
FOR INVESTORS
Date:
September 29, 2021
Time:
12:00 am - 12:00 am
NEWS ARCHIVES
Watch Now
You May Also Like
Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase | Oncotarget
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease | NEJM
Go to Top